Home › Biogen Idec's TECFIDERA (Dimethyl Fumarate) Approved In US As A First-Line Oral Treatment For Multiple Sclerosis
 

Keywords :   


Biogen Idec's TECFIDERA (Dimethyl Fumarate) Approved In US As A First-Line Oral Treatment For Multiple Sclerosis

2013-03-27 17:10:00| dairynetwork News Articles

Recently Biogen Idec announced that the U.S. Food and Drug Administration (FDA) has approved TECFIDERA (dimethyl fumarate), a new first-line oral treatment for people with relapsing forms of multiple sclerosis (MS).

Tags: multiple treatment approved oral

Category:Agriculture and Forestry

Latest from this category

All news
28.06Cattle producers celebrate Supreme Court decision to rein in administrative overreach
28.06Commitment leads to success in cattle marketing
28.06Cost of summer cookout reaches record high
28.06Farm Progress America, June 28, 2024
28.06Farm Progress America, June 28, 2024
28.06USDA moves to change livestock competition rules
28.06Learning to listen to nursery pigs
27.06Texas & Southwestern Cattle Raisers Association concludes 2024 summer meeting
Agriculture and Forestry »
29.06Atlantic Tropical Weather Outlook
29.06Eastern North Pacific Tropical Weather Outlook
28.06What we learned from IT expert at Post Office inquiry
28.06M&S to launch clothing repairs service
28.06Tropical Depression Two Graphics
28.06Tropical Depression Two Public Advisory Number 1
28.06Summary for Tropical Depression Two (AT2/AL022024)
28.06Tropical Depression Two Forecast Advisory Number 1
More »